Strategic Partnerships Atomo Diagnostics has formed and pursued collaborations with industry players such as BBI Solutions and Burnet Institute, signaling a preference for joint development and distribution strategies. There is a clear opportunity to position complementary diagnostics technologies, distribution channels, or co-developed rapid tests through similar partnerships in key markets.

Geographic Expansion The company has actively expanded into New Zealand and Australia with ambitions in Oceania, and maintains offices in South Africa and the UK. This indicates receptivity to regional partnerships and local regulatory-ready deployments; sales efforts can target governmental and institutional tenders, as well as channel partners in these regions.

Public Sector Funding Recent government and research funding supports rapid test development and infectious disease diagnostics, including grants and government-funded orders. Opportunities exist to pursue tender opportunities, government-funded programs, and CRCP or similar grants to finance new test deployments and scale production capacity.

Self Test Growth Growth in HIV self-testing and other point-of-care tests is highlighted, with government-funded orders in Australia and expansion plans in Oceania. This suggests demand for consumer-friendly, compliant rapid tests and related accessory ecosystems, offering upsell potential to institutions and retail partners.

Scale and Capacity Funding rounds and plans to scale Pascal cassette supply indicate readiness to accelerate production to meet rising demand. Sales conversations can frame capacity expansion as a differentiator, enabling commitments for larger multi-year supply agreements and faster lead times in high-demand markets.